Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-week) Study-

Update Il y a 4 ans
Reference: NCT00449046

Woman and Man

  • | Country :
  • Japan
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study evaluates the long-term (24-week) safety and efficacy of GW815SF Salmeterol/fluticasone propionate(HFA MDI) 50/100mcg(administered as 2 inhalations of 25/50mcg) bid in pediatric patients with bronchial asthma.


Inclusion criteria

  • Bronchial asthma

Links